Home > Publications > Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity.
Centenary Institute - Medical Research
Centenary Institute - Medical Research

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity.

Williams KH, Vieira De Ribeiro AJ, Prakoso E, Veillard A-S, Shackel NA, Brooks B, Bu Y, Cavanagh E, Raleigh J, McLennan SV, McCaughan, GW, Bachovchin, WW, Keane, FM, Zekry, A, Twigg, SM, Gorrell, MD.

Diabetes Research and Clinical Practice 108, 466-472. PMID 25836944.

Date: 2015